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Abstract: A 61-year-old man presented to the ophthalmology department having developed 
bilateral branch retinal vein occlusions. Baseline blood tests revealed no abnormality; however, 
subsequent investigations showed a raised plasma homocysteine (HC) level. The patient has 
been treated for refractory epilepsy for a number of years. Although antiepileptic medications 
have been shown to reduce folate levels and result in a raised HC level, this has not previously 
been shown to be to a level causing a retinal vascular event.
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Introduction
Retinal vein occlusions are the second most common retinal vascular disease follow-
ing diabetic retinopathy. A combination of hypertensive, atherosclerotic, inflamma-
tory, or thrombophilic conditions may lead to retinal endothelial vascular damage. 
Hyperhomocysteinemia has been implicated as an independent risk factor for systemic 
vascular events, including retinal vascular disease. We present a case demonstrating 
the potential biochemical implications of antiepileptic agents and discuss their role 
in retinal vascular events.
Case history
A 61-year-old man was referred to the ophthalmology clinic by his optician for fundal 
changes noted at a routine eye examination. He was completely visually asymptomatic, 
with no past ocular history of note. His medical history included epilepsy, which had 
been difficult to control, for which he took phenytoin, topiramate, and pregabalin. 
There was no history of diabetes, hypertension, or cardiovascular disease, nor any 
family history of note. He smoked occasionally and drank little alcohol.
On examination, his visual acuity was 6/4 (20/13) in the right eye and 6/5 (20/15) 
in the left eye; anterior segment examination was normal with intraocular pressures 
within the normal range. Dilated fundal examination revealed right macular exudates 
and subretinal fluid, suggestive of a branch retinal vein occlusion (BRVO). In the left 
eye he demonstrated a few scattered retinal hemorrhages along the superotemporal 
arcade (Figure 1).
The patient’s blood pressure was normal (117/70 mm Hg). He underwent a series 
of blood tests, revealing a normal full blood count, electrolytes, cholesterol, lipids 
and triglycerides, fasting glucose, autoantibodies, C3, C4, immunoglobulins, and 
thrombophilia screen. His only abnormality detected was a high serum homocysteine Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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(HC) level (20 umol/L). He was started on folate therapy, 
as this was considered the most likely cause of his raised 
HC level secondary to his antiepileptic medication but was 
subsequently discontinued as he noticed an increase in his 
seizure rate.
At his review appointment 2 months later, the patient 
reported a deterioration in the vision in his left eye; exami-
nation revealed a visual acuity of 6/24 (20/80), extensive 
retinal hemorrhages along the superotemporal arcade, and 
diffuse macular edema. The visual acuity in the right eye 
remained satisfactory at 6/9 (20/30). His fluorescein angio-
gram revealed a right superotemporal BRVO with evidence 
of some macular edema and leakage; the left eye showed 
evidence of a superotemporal BRVO with extensive retinal 
hemorrhages and some late leakage around the macular 
region (Figure 2).
The patient underwent argon macular grid laser therapy 
to his left eye, which improved his acuity to 6/12 (20/40). 
He continues to be monitored.
Discussion
Antiepileptic drugs (AEDs) have been shown to be related 
to atherosclerosis and vascular risk.1 Even in children 
utilizing AEDs, cytochrome P450 liver enzyme-inducing 
agents such as carbamezapine, phenytoin, and phenobarbital 
have caused rises in cholesterol, triglycerides, and low-
density lipoprotein levels. The effects may be reversible, 
as switching to alternative AEDs such as levetiracem or 
lamotrigine has been shown to correct such biochemical 
abnormalities.2
The role of plasma HC has been suggested. The use of 
AEDs such as carbamezapine and sodium valproate have 
been shown to cause an increase in plasma HC levels,3 most 
likely due to disruption of folate metabolism. HC itself is 
well known to be an independent risk factor for vascular 
events.4 The mechanism of action remains uncertain, but 
suggestions include oxidative damage of endothelial cells, 
dysregulation of endothelial function due to endothelial 
nitric oxide synthase impairment, promotion of endothelial 
thrombotic functions such as platelet activation, and inflam-
matory processes.1 The relationship between HC and retinal 
vascular occlusion has also been well documented, both 
for central retinal vein occlusions5–9 and for branch vein 
occlusions.10,11 Although the false-positive rate for raised 
serum HC is approximately 5%, making the test unsuitable 
for screening purposes, the dose-dependent relationship 
between HC levels and risk of cardiovascular disease is a 
factor not to be taken lightly in individuals who have had 
a vascular event.12
Cardiovascular events, including retinal vascular diseases, 
have a multifactorial causality, combining both occlusive and 
inflammatory parameters. This case demonstrates a potential 
causal factor involved that is often overlooked. Although 
HC levels have been related to AEDs, and raised plasma 
HC has been linked to vascular events, this is the first report 
of bilateral branch vein occlusion in a patient utilizing such 
antiepileptic agents. The potential risks of these AEDs ought 
to be respected and remembered when considering the choice 
of agents in patients, both young and old, when managing 
their seizures.
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Figure 1 Color fundal photos demonstrating signs of branch vein occlusions in both 
left and right eyes.
Figure 2 Fluorescein angiograms demonstrating bilateral branch vein occlusions 
with left macular edema.Clinical Ophthalmology
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